Will data privacy impact health research?

Drug Information Journal

Volumn 36, Issue 2, 2002, Pages 465-480

  Knudsen, Lisbeth Ehlert ^a   Due Theilade, Mette ^a   Gordon, Arnold ^a   Mascaro, Jacques ^a   Bruppacher, Rudolf ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

Data privacy; Directive 95 46 EC; European Community

Indexed keywords

CONFERENCE PAPER; EUROPEAN UNION; GENETICS; GENOMICS; INFORMATION PROCESSING; LAW; LICENSING; MEDICAL ETHICS; MEDICAL RESEARCH; PHARMACOGENOMICS; PRIORITY JOURNAL; PRIVACY; VALIDATION PROCESS;

EID: 0036374943     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150203600227     Document Type: Conference Paper

References (4)

1. European Community. Directive 95/46/EC of the European Parliament and the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data. Brussels, Belgium: European Community Commission; 1995.
2. Lowrance WW. The promise of human genetic data-bases. High ethical as well as scientific standards are needed. Br Med J. 2001;322(7293):1009-1010.
3. Knudsen LE, Renneberg J. Regulatory aspects of the application of pharmacogenetics in drug discovery and development in Europe. Good Clin Pract. 2000; 7(6):11-13.
4. Theilade MD, Ehlert Knudsen L, Renneberg J. Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials in Europe. Regulatory Aff J. 2001;12(2):92-99.